Ioana Preston
Experienced in Grass Allergy

Dr. Ioana Preston

Intensive Care Medicine
Tufts Medical Center
800 Washington St, 
Boston, MA 
Offers Telehealth
Experienced in Grass Allergy
Tufts Medical Center
800 Washington St, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ioana Preston is an Intensive Care Medicine provider in Boston, Massachusetts. Dr. Preston is rated as an Experienced provider by MediFind in the treatment of Grass Allergy. Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Cerebral Hypoxia, and Lung Transplant.

Her clinical research consists of co-authoring 90 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in RI
Hospital Affiliations
Winchester Hospital
Lahey Hospital & Medical Center, Burlington
Northeast Hospital Corporation
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Tufts Medical Center
800 Washington St, Boston, MA 02111
Call: 617-636-6377
Other Locations
Lahey Hospital & Medical Center
41 Mall Rd, Burlington, MA 01805
Call: 781-744-8000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
A Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) Subcutaneous Injections in Pulmonary Arterial Hypertension Subjects Following Completion of Study PB1046-PT-CL-0004
Enrollment Status: Terminated
Publish Date: February 22, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

90 Total Publications

Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
Journal: The New England journal of medicine
Published: September 30, 2025
View All 90 Publications
Similar Doctors
Douglas M. Beach
Distinguished in Grass Allergy
Dr. Douglas M. Beach
Internal Medicine | Intensive Care Medicine
Distinguished in Grass Allergy
Dr. Douglas M. Beach
Internal Medicine | Intensive Care Medicine

Beth Israel Deaconess Medical Center

330 Brookline Avenue, Shapiro 7, 
Boston, MA 
 (11.3 miles away)
617-667-5864
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Beach is an Internal Medicine specialist and an Intensive Care Medicine provider in Boston, Massachusetts. Dr. Beach is rated as a Distinguished provider by MediFind in the treatment of Grass Allergy. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Grass Allergy.

Ali Khodabandeh
Distinguished in Grass Allergy
Dr. Ali Khodabandeh
Intensive Care Medicine
Distinguished in Grass Allergy
Dr. Ali Khodabandeh
Intensive Care Medicine

Mass Lung & Allergy PC

100 Hospital Rd Ste 2A, 
Leominster, MA 
 (28.5 miles away)
978-466-2692
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ali Khodabandeh is an Intensive Care Medicine provider in Leominster, Massachusetts. Dr. Khodabandeh is rated as a Distinguished provider by MediFind in the treatment of Grass Allergy. His top areas of expertise are Asthma in Children, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Lung Metastases, and Pacemaker Implantation.

Advanced in Grass Allergy
Dr. Barry M. Pisick
Intensive Care Medicine | Pulmonary Medicine
Advanced in Grass Allergy
Dr. Barry M. Pisick
Intensive Care Medicine | Pulmonary Medicine
145 Ward Hill Ave, 
Bradford, MA 
 (19.7 miles away)
978-764-2170
Languages Spoken:
English
See accepted insurances

Barry Pisick is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Bradford, Massachusetts. Dr. Pisick is rated as a Distinguished provider by MediFind in the treatment of Grass Allergy. His top areas of expertise are Asthma in Children, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Lung Metastases.

VIEW MORE GRASS ALLERGY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Preston's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Preston is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
    • Advanced
    • Cerebral Hypoxia
      Dr. Preston is
      Advanced
      . Learn about Cerebral Hypoxia.
      See more Cerebral Hypoxia experts
    • Heart Failure with Preserved Ejection Fraction (HFpEF)
      Dr. Preston is
      Advanced
      . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
      See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
    • Pulmonary Veno-Occlusive Disease
      Dr. Preston is
      Advanced
      . Learn about Pulmonary Veno-Occlusive Disease.
      See more Pulmonary Veno-Occlusive Disease experts
    • Experienced
    • Acute Interstitial Pneumonia
      Dr. Preston is
      Experienced
      . Learn about Acute Interstitial Pneumonia.
      See more Acute Interstitial Pneumonia experts
    • Asthma
      Dr. Preston is
      Experienced
      . Learn about Asthma.
      See more Asthma experts
    • Asthma in Children
      Dr. Preston is
      Experienced
      . Learn about Asthma in Children.
      See more Asthma in Children experts
    • Chronic Obstructive Pulmonary Disease (COPD)
      Dr. Preston is
      Experienced
      . Learn about Chronic Obstructive Pulmonary Disease (COPD).
      See more Chronic Obstructive Pulmonary Disease (COPD) experts
    • Grass Allergy
      Dr. Preston is
      Experienced
      . Learn about Grass Allergy.
      See more Grass Allergy experts
    • Interstitial Lung Disease
      Dr. Preston is
      Experienced
      . Learn about Interstitial Lung Disease.
      See more Interstitial Lung Disease experts
    View All 13 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment